Nesta página
01ZBH preço
02Instantâneo
03Gráfico
04Divisões de Ações
05Sobre
06Desempenho
07Avaliação e rácios
13Dividendos
14Lucros
15Fundamentos Completos
16Demonstrações
17Investidores institucionais (13F)
18Ativistas e proprietários de 5%+
19Executivos da empresa
20Participação em ETFs
21Consenso
22Pares
23Notícias
25Sinais de trading
26Minhas Métricas
ZBH Zimmer Biomet Holdings, Inc. Common Stock
NYSE · Health Care · Ver em SEC EDGAR ↗ fechar Out 5, 2026 10-K/10-Q Ago 5, 2026
$91,57
· % da faixa de 52 semanas
· acima do mínimo
· para alta
$79,12mínima 52 sem
$106,88máxima 52 sem
Capitalização de Mercado (MRQ)
$29.25B
P/E (TTM)
22.2
EPS (TTM)
$4.12
Receita (TTM)
$8.51B
seus distintivos
Intervalo 52 Semanas
$79–$107
Classificação do Analista
HOLD
Preço-Alvo
$108
P/E
22.2
ROE
6.4%
Margem de Lucro Líquido
9.5%
Sua barra de distintivos está vazia — fixe uma métrica em qualquer lugar desta página.
ZBH Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$91.57
Capitalização de Mercado (MRQ)
$29.25B
P/E (TTM)
22.2
EPS (TTM)
$4.12
Receita (TTM)
$8.51B
Rendimento div.
0.65%
ROE (TTM)
6.4%
Dívida/Capital (MRQ)
0.6
Intervalo 52 Semanas
$79–$107
ZBH Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
intervalo
barras
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
Divisões de Ações
| Data ex | Desdobramento | Tipo |
|---|---|---|
| 1 de Março de 2022 | 103-for-100 | Para frente |
Sobre Zimmer Biomet Holdings, Inc. Common Stock Visão geral da empresa da Wikipedia
Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
In 2001, Zimmer was spun off from Bristol Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. (ExtraOrtho). In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet.
On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook.
History
Zimmer Biomet was established in 1927 by Justin O. Zimmer (1884–1951) in Warsaw, Indiana.
On April 24, 2014, it was announced that Zimmer had agreed to purchase Biomet Inc. for $13.4 billion. In October 2014, however, it was announced that the EU's antitrust regulators had opened an extensive investigation into Zimmer's bid for Biomet due to concern that it would substantially lessen competition in certain markets. In March 2016, European Commission (“EC”) conditionally cleared Zimmer's proposed acquisition of Biomet, Inc. and on June 24, 2015, Zimmer completed its acquisition of Biomet forming Zimmer Biomet Holdings.
In October 2014, the company announced it would acquire ETEX Holdings, Inc.
In March 2016, Zimmer Biomet announced it would acquire Ortho Transmission, LLC. The company also announced it would acquire sports medicine company, Cayenne Medical, Inc. Later in the same year the company acquired medical device manufacturer, LDR Holding Corporation for $37 per share ($1 billion in total), merging it into their Spine division. In July, the company acquired French surgical robotics company Medtech. In August, the company announced it was acquiring Delaware-based CD Diagnostics, a diagnostics company developing immunoassays and biomarker testing. In September, Zimmer announced the acquisition of Clinical Graphics, B.V.
The Justin Zimmer House in Warsaw is listed on the National Register of Historic Places.
In January 2023, the company announced its intention to acquire Embody, Inc. for $155 million (plus a potential $120 million in milestones).
In August 2024, Zimmer Biomet announced plans to acquire OrthoGrid Systems, an AI surgical guidance company, in order to expand its market share in hip replacement procedures.
In 2026, Zimmer Biomet acquired the iovera pain therapy business from Pacira BioSciences Inc. for $140 million.
Products
Zimmer designs, develops, manufactures and markets orthopedics products, including knee, hip, shoulder, elbow, foot and ankle artificial joints and dental prostheses. In 2024, Zimmer introduced the ROSA Shoulder, said to be the world's first robotic surgery system for shoulder replacement, and the fourth application for the company's ROSA Robotics portfolio, which includes the ROSA Knee System for total knee arthroplasty and ROSA Hip System for total hip replacement. Zimmer has operations in more than 40 countries around the world (US, Australia, Austria, Belgium, Canada, China, Czech Republic, Finland, France, Germany, India, Ireland, Israel, Italy, Japan, Latin America, Netherlands, Brasil, Poland, Portugal, Russia, South Africa, Spain etc.) and sells products in more than 100 countries.
Acquisition history
The following is an illustration of the company's major mergers, acquisitions and historical predecessors:
Company data
Zimmer's 2023 sales were approximately $7.4 billion. The company has approximately 18,000 employees worldwide.
Leadership
Raymond Elliott was president and CEO from August 2001 to May 2007.
David C. Dvorak, was president and CEO from May 1, 2007, to July 11, 2017.
Dan Florin, Interim President and CEO from July 11, 2017, to December 19, 2017.
Bryan C. Hanson, President and CEO from December 19, 2017 to August 22, 2023.
Ivan Tornos, President and CEO from August 22, 2023, to present.
Recognition
In 2016, the company was recognized on the Fortune 500 list for the first time, ranking in position #431. As of 2026, the company is ranked 463rd on the list.
Criticism
During the 2022 Russian invasion of Ukraine, Zimmer Biomet continued to sell to the Russian market. Research from Yale University updated on April 28, 2022, identifying how companies were reacting to Russia's invasion identified Zimmer Biomet as continuing business-as-usual in Russia: companies defying demands for exit/reduction of activities.
Public-private engagement
Activism
Zimmer Biomet is a corporate partner of Human Rights Campaign, a large LGBT advocacy organization.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
setorHealth Care
indústriaHealth Care
funcionários17.000
paísUS
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita$8.23B2016-12-31 → 2025-12-31
EPS$3.552016-12-31 → 2025-12-31
Fluxo de caixa livre$1.47B2016-12-31 → 2025-12-31
Margem líquida9.5%2016-12-31 → 2025-12-31
Avaliação e Proporções
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | ZBH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | 22.2média 5A ≈50.9 | ≈50.9 | 28.6 | Subvalorizado | |
| P/S (TTM) | 3.4média 5A ≈4.9 | ≈4.9 | 4.4 | Subvalorizado | |
| P/B (MRQ) | 2.3média 5A ≈2.9 | ≈2.9 | 4.7 | Subvalorizado | |
| EV / EBITDA | 16.5média 5A ≈21.1 | ≈21.1 | 17.3 | Subvalorizado | |
| Preço / FCF (TTM) | 19.2média 5A ≈27.7 | ≈27.7 | · | · | |
| Preço / Fluxo de Caixa (TTM) | 16.8média 5A ≈23.8 | ≈23.8 | 21.9 | Subvalorizado | |
| EV / Revenue (EV / Receita) | 4.4média 5A ≈5.7 | ≈5.7 | · | · | |
| EV / FCF | 24.6média 5A ≈32.2 | ≈32.2 | · | · | |
| Preço / Valor Patrimonial Tangível (MRQ) | 3.6 | · | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | ZBH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Operacional (TTM) | 14.2%média 5A ≈13.5% | ≈13.5% | 15.6% | Em linha | |
| Margem EBITDA (TTM) | 27.2%média 5A ≈26.7% | ≈26.7% | 15.6% | Em linha | |
| Margem de Impostos Pré-Tributação (TTM) | 11.0%média 5A ≈9.8% | ≈9.8% | 14.0% | Fraco | |
| Margem de Lucro Líquido (TTM) | 9.5%média 5A ≈8.5% | ≈8.5% | 11.2% | Fraco | |
| ROA (TTM) | 3.5%média 5A ≈3.0% | ≈3.0% | 8.0% | Fraco | |
| ROE (TTM) | 6.4%média 5A ≈5.3% | ≈5.3% | 14.8% | Fraco | |
| ROIC | 4.6%média 5A ≈4.8% | ≈4.8% | 10.9% | Fraco |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | ZBH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido (MRQ) | 0.6média 5A ≈0.5 | ≈0.5 | 0.2 | Dívida alta | |
| Índice de liquidez corrente (MRQ) | 1.7média 5A ≈1.8 | ≈1.8 | 1.8 | Baixa liquidez | |
| Quick Ratio (Índice de Liquidez Seca) | 0.9média 5A ≈0.7 | ≈0.7 | 0.9 | Baixa liquidez | |
| Dívida de Longo Prazo / Patrimônio Líquido (MRQ) | 0.5média 5A ≈0.4 | ≈0.4 | 0.5 | Em linha |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | ZBH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | 7.2%média 5A ≈6.1% | ≈6.1% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | 5.9%média 5A ≈5.4% | ≈5.4% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | 6.1% | · | · | · | |
| EPS YoY | -19.9%média 5A ≈68.0% | ≈68.0% | · | · | |
| Net Income YoY (Lucro Líquido Ano a Ano) | -22.0%média 5A ≈66.6% | ≈66.6% | · | · | |
| EPS CAGR 3Y (CAGR de LPA 3A) | 47.8% | · | · | · | |
| Net Income CAGR 3Y (CAGR de Lucro Líquido 3A) | 45.0% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | ZBH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 0.4média 5A ≈0.3 | ≈0.3 | 0.6 | Fraco | |
| Inventory Turnover (Giro de Estoque) | 1.1média 5A ≈1.0 | ≈1.0 | 2.4 | Fraco | |
| Receivables Turnover (Giro de Contas a Receber) | 5.2média 5A ≈5.3 | ≈5.3 | 6.2 | Fraco | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$484.2K | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos
Dividend Yield0.65%
Índice de Pagamento27.0%
Pagamento Anualizado≈$0.96
CAGR Dividendos 5 anos≈0.59%
| Data ex | Valor | Moeda | Rendimento |
|---|---|---|---|
| Set 30, 2026 | $0,24 | USD | ≈1.1% |
| Jun 25, 2026 | $0,24 | USD | ≈1.1% |
| Mar 31, 2026 | $0,24 | USD | ≈1.1% |
| Dez 30, 2025 | $0,24 | USD | ≈1.1% |
| Set 30, 2025 | $0,24 | USD | ≈0.97% |
| Jun 26, 2025 | $0,24 | USD | ≈1.0% |
| Mar 31, 2025 | $0,24 | USD | ≈0.85% |
| Dez 30, 2024 | $0,24 | USD | ≈0.91% |
| Set 30, 2024 | $0,24 | USD | ≈0.89% |
| Jun 26, 2024 | $0,24 | USD | ≈0.89% |
| Mar 27, 2024 | $0,24 | USD | ≈0.72% |
| Dez 26, 2023 | $0,24 | USD | ≈0.79% |
| Set 28, 2023 | $0,24 | USD | ≈0.85% |
| Jun 23, 2023 | $0,24 | USD | ≈0.67% |
| Mar 28, 2023 | $0,24 | USD | ≈0.76% |
| Dez 23, 2022 | $0,24 | USD | ≈0.76% |
| Set 29, 2022 | $0,24 | USD | ≈0.89% |
| Jun 24, 2022 | $0,24 | USD | ≈0.87% |
| Mar 28, 2022 | $0,24 | USD | ≈0.75% |
| Dez 27, 2021 | $0,23 | USD | ≈0.75% |
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
3.0%
Próximo relatório
Nov 03, 2026
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Ago 5, 2026 | $2.07 | $2.03 | 2.0% |
| 31 de Março de 2026 | $2.09 | $1.88 | 11.0% | |
| 31 de Dezembro de 2025 | $2.42 | $2.42 | 0.00% | |
| 30 de Setembro de 2025 | $1.90 | $1.89 | 0.73% | |
| 30 de Junho de 2025 | $2.07 | $2.00 | 3.3% | |
| 31 de Março de 2025 | $1.81 | $1.79 | 1.2% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.23B | $7.68B | $7.39B | $6.94B | $6.83B | $6.13B | $7.98B | $7.93B | $7.80B | $7.67B | $6.00B | $4.67B | |
| Cost of Revenue | $2.49B | $2.19B | $2.08B | $2.02B | $1.96B | $1.82B | $2.25B | $2.27B | $2.13B | $2.38B | $1.80B | $1.24B | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | · | $3.42B | |
| SG&A Expense | $3.26B | $2.93B | $2.84B | $2.76B | $2.84B | $2.71B | $3.34B | $3.38B | $3.10B | $2.94B | $2.28B | $1.75B | |
| Operating Expenses | $7.13B | $6.39B | $6.12B | $6.24B | $5.97B | $6.04B | $6.84B | $7.90B | $7.00B | $6.85B | $5.53B | $3.64B | |
| Operating Income | $1.10B | $1.29B | $1.28B | $696M | $860M | $83M | $1.14B | $34M | $799M | $821M | $467M | $1.04B | |
| Interest Income | · | · | · | · | · | · | · | · | $2M | $3M | $9M | $12M | |
| Other Non-op | $26M | $-31M | $-9M | $-128M | $12M | $24M | $-5M | $-16M | $-9M | $-66M | $-37M | $-47M | |
| Pretax Income | $831M | $1.04B | $1.07B | $404M | $499M | $-105M | $906M | $-271M | $465M | $400M | $153M | $939M | |
| Income Tax | $126M | $131M | $42M | $112M | $54M | $-96M | $-226M | $108M | $-1.35B | $95M | $7M | $220M | |
| Net Income | $705M | $904M | $1.02B | $231M | $402M | $-139M | $1.13B | $-379M | $1.81B | $306M | $147M | $720M | |
| EPS (Basic) | $3.56 | $4.45 | $4.91 | $1.10 | $1.93 | $-0.67 | $5.52 | $-1.86 | $8.98 | $1.53 | $0.78 | $4.26 | |
| EPS (Diluted) | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 | $-0.67 | $5.47 | $-1.86 | $8.90 | $1.51 | $0.77 | $4.20 | |
| Shares (Basic) | 198,000,000 | 203,100,000 | 208,700,000 | 209,600,000 | 208,600,000 | 207,000,000 | 205,100,000 | 203,500,000 | 201,900,000 | 200,000,000 | 187,400,000 | 169,000,000 | |
| Shares (Diluted) | 198,700,000 | 203,900,000 | 209,700,000 | 210,300,000 | 210,400,000 | 207,000,000 | 206,700,000 | 203,500,000 | 203,700,000 | 202,400,000 | 189,800,000 | 171,700,000 | |
| EBITDA | $2.19B | $2.28B | $2.23B | $1.62B | $1.85B | $945M | $2.14B | $1.07B | $1.87B | $1.87B | $1.18B | $1.41B |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $592M | $526M | $416M | $376M | $378M | $802M | $618M | $543M | $524M | $634M | $1.46B | $1.08B | |
| Receivables | $1.70B | $1.48B | $1.44B | $1.38B | $1.26B | $1.45B | $1.36B | $1.28B | $1.54B | $1.60B | $1.45B | $912M | |
| Inventory | $2.29B | $2.24B | $2.39B | $2.15B | $2.15B | $2.45B | $2.38B | $2.26B | $2.07B | $1.96B | $2.25B | $1.19B | |
| Prepaid Expense | $537M | $430M | $366M | $523M | $271M | $169M | $357M | $352M | $428M | $466M | $529M | $317M | |
| Current Assets | $5.12B | $4.67B | $4.61B | $4.43B | $4.88B | $5.08B | $4.72B | $4.43B | $4.56B | $4.66B | $5.85B | $4.31B | |
| PP&E (Net) | $2.21B | $2.05B | $2.06B | $1.87B | $1.84B | $2.05B | $2.08B | $2.02B | $2.04B | $2.04B | $2.06B | $1.29B | |
| PP&E (Gross) | $7.26B | $6.69B | $6.77B | $6.46B | $6.14B | $6.32B | $5.92B | $5.44B | $5.08B | $4.67B | $4.43B | $3.41B | |
| Accum. Depreciation | $5.05B | $4.64B | $4.71B | $4.59B | $4.30B | $4.28B | $3.84B | $3.42B | $3.05B | $2.63B | $2.37B | $2.12B | |
| Goodwill | $9.95B | $8.95B | $8.82B | $8.58B | $8.92B | $8.98B | $9.60B | $9.59B | $10.67B | $10.64B | $9.93B | $2.51B | |
| Intangibles | $4.72B | $4.60B | $4.86B | $5.06B | $5.53B | $7.06B | $7.26B | $7.68B | $8.35B | $8.79B | $8.75B | $604M | |
| Other Non-current Assets | $1.10B | $1.10B | $1.15B | $1.12B | $1.00B | $969M | $980M | $405M | $389M | $554M | $564M | $942M | |
| Total Assets | $23.09B | $21.37B | $21.50B | $21.07B | $23.46B | $24.42B | $24.64B | $24.13B | $26.01B | $26.68B | $27.16B | $9.66B | |
| Accounts Payable | $303M | $195M | $411M | $354M | $306M | $330M | $401M | $363M | $330M | $364M | $285M | $145M | |
| Accrued Liabilities | $834M | $706M | $804M | $582M | $536M | $873M | $778M | $671M | $775M | $789M | $726M | $351M | |
| Current Liabilities | $2.58B | $2.45B | $2.86B | $2.36B | $3.47B | $2.56B | $3.44B | $2.42B | $3.07B | $2.38B | $1.62B | $1.02B | |
| Capital Leases | $176M | $190M | $174M | $167M | $175M | $218M | $216M | · | · | · | · | · | |
| Deferred Tax | $244M | $352M | $358M | $475M | $558M | $790M | $840M | $1000M | $1.10B | $3.03B | $3.15B | $46M | |
| Other Non-current Liabilities | $626M | $744M | $926M | $633M | $548M | $656M | $558M | $350M | $446M | $463M | $1.01B | $611M | |
| Total Liabilities | $10.39B | $8.89B | $9.01B | $9.04B | $10.79B | $12.22B | $12.25B | $12.85B | $14.28B | $17.01B | $17.27B | $3.11B | |
| Long-term Debt | $7.52B | $6.20B | $5.77B | $5.70B | $1.00B | $8.13B | $8.22B | $8.94B | $10.14B | $11.24B | · | · | |
| Total Debt | $7.52B | $6.20B | $5.77B | $5.70B | $7.07B | $8.13B | $8.22B | $8.94B | $10.14B | $11.24B | $11.56B | $1.43B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Retained Earnings | $11.61B | $11.10B | $10.38B | $9.56B | $10.29B | $10.09B | $10.43B | $9.49B | $10.02B | $8.47B | $8.35B | $8.36B | |
| Treasury Stock | $8.89B | $8.41B | $7.56B | $6.87B | $6.72B | $6.72B | $6.72B | $6.72B | $6.72B | $6.74B | $6.33B | $6.18B | |
| AOCI | $-206M | $-263M | $-191M | $-179M | $-232M | $-298M | $-242M | $-187M | $-83M | $-434M | $-329M | $38M | |
| Stockholders' Equity | $12.70B | $12.47B | $12.48B | $12.02B | $12.66B | $12.19B | $12.39B | $11.27B | $11.74B | $9.67B | $9.89B | $6.55B | |
| Liabilities + Equity | $23.09B | $21.37B | $21.50B | $21.07B | $23.46B | $24.42B | $24.64B | $24.13B | $26.01B | $26.68B | $27.16B | $9.66B | |
| Shares Outstanding | 318,700,000 | 317,500,000 | 316,200,000 | 313,800,000 | 312,800,000 | 311,400,000 | 309,900,000 | 307,900,000 | 306,500,000 | 304,700,000 | 302,700,000 | 268,400,000 |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.09B | $996M | $952M | $926M | $938M | $898M | $1.01B | $1.04B | $1.06B | $1.04B | $712M | $376M | |
| Stock-based Comp | $90M | $101M | $100M | $105M | $76M | $74M | $84M | $66M | $54M | $57M | $46M | $49M | |
| Deferred Tax | $-87M | $-48M | $-96M | $-64M | $-102M | $39M | $-539M | $13M | $-1.78B | $-153M | $-164M | $-90M | |
| Amort. of Intangibles | $666M | $592M | $562M | $527M | $530M | $512M | $584M | $596M | $604M | $566M | $337M | $92M | |
| Restructuring | · | · | · | · | $32M | · | · | · | $17M | $91M | $196M | · | |
| Other Non-cash | $-105M | $-454M | $-398M | $158M | $95M | $219M | $-98M | $1.01B | $428M | $383M | $75M | $-8M | |
| Operating Cash Flow | $1.70B | $1.50B | $1.58B | $1.36B | $1.40B | $1.08B | $1.59B | $1.75B | $1.58B | $1.63B | $850M | $1.06B | |
| CapEx | $224M | $204M | $291M | $188M | $144M | $112M | $207M | $163M | $156M | $185M | $168M | $145M | |
| Investing Cash Flow | $-1.98B | $-888M | $-779M | · | $-504M | $-614M | $-729M | $-417M | $-511M | $-1.69B | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $750M | $3.00B | · | |
| Net Debt Issued | · | · | · | · | · | · | · | $-1.43B | $-940M | $-50M | $2.50B | · | |
| Stock Repurchased | $487M | $868M | $692M | $126M | · | · | · | · | · | $416M | $150M | $401M | |
| Net Stock Activity | $-487M | $-868M | $-692M | $-126M | · | · | · | · | · | $-416M | $-150M | $-400M | |
| Dividends Paid | $190M | $196M | $201M | $201M | $200M | $198M | $197M | $195M | $194M | $188M | $157M | $146M | |
| Financing Cash Flow | $326M | $-484M | $-764M | · | $-1.31B | $-422M | $-780M | $-1.30B | $-1.21B | $-743M | · | · | |
| Net Change in Cash | $66M | $110M | $40M | $-103M | $-324M | $184M | $75M | $18M | $-110M | $-825M | $376M | $3M | |
| Taxes Paid | $377M | $328M | $215M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.47B | $1.30B | $1.29B | $1.17B | $1.33B | $1.09B | $1.38B | $1.58B | $1.43B | $1.45B | $649M | $908M |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | · | · | 73.3% | |
| Operating Margin | 13.3% | 16.7% | 17.3% | 10.0% | 10.0% | -1.2% | 14.2% | 0.43% | 10.3% | 10.8% | 7.8% | 22.1% | |
| Net Margin | 8.6% | 11.8% | 13.9% | 3.3% | 5.1% | -2.0% | 14.2% | -4.8% | 23.2% | 4.0% | 2.5% | 15.4% | |
| Pretax Margin | 10.1% | 13.5% | 14.4% | 5.8% | 5.3% | -3.9% | 11.3% | -3.4% | 5.9% | 5.2% | 2.5% | 20.2% | |
| EBITDA Margin | 26.6% | 29.7% | 30.1% | 23.4% | 23.6% | 13.5% | 26.9% | 13.5% | 23.9% | 24.3% | 19.7% | 30.2% | |
| ROA | 3.2% | 4.2% | 4.8% | 1.0% | 1.7% | -0.57% | 4.6% | -1.5% | 6.9% | 1.1% | 0.54% | 7.5% | |
| ROE | 5.6% | 7.2% | 8.4% | 1.9% | 3.2% | -1.1% | 9.6% | -3.3% | 17.0% | 3.1% | 1.5% | 11.2% | |
| ROIC | 4.6% | 6.0% | 6.7% | 2.8% | 3.8% | -0.22% | 6.9% | 0.23% | 14.4% | 3.0% | 2.1% | 9.9% |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.9 | 1.6 | 1.9 | 1.4 | 2.0 | 1.4 | 1.8 | 1.5 | 2.0 | 3.6 | 4.1 | |
| Quick Ratio | 0.9 | 0.8 | 0.7 | 0.7 | 0.5 | 0.9 | 0.6 | 0.8 | 0.7 | 0.9 | 1.8 | 1.9 | |
| Debt / Equity | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 | 0.7 | 0.7 | 0.8 | 0.9 | 1.2 | 1.2 | 0.2 | |
| LT Debt / Equity | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | 0.6 | 0.5 | 0.7 | 0.8 | 1.1 | 1.2 | 0.2 |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.5 | |
| Inventory Turnover | 1.1 | 0.9 | 0.9 | 0.9 | 1.0 | 0.9 | 1.0 | 1.1 | 1.1 | 1.1 | 0.8 | 1.1 | |
| Receivables Turnover | 5.2 | 5.3 | 5.2 | 5.3 | 5.5 | 5.0 | 6.0 | 5.6 | 5.0 | 5.0 | 5.1 | 5.1 |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $39.84 | $39.27 | $39.47 | $38.31 | $40.48 | $39.16 | $39.97 | $36.61 | $38.29 | $31.73 | $32.67 | · | |
| Revenue / Share | $41.43 | $37.66 | $35.26 | $33.00 | $37.24 | $33.93 | $38.62 | $38.98 | $38.41 | $37.96 | $31.60 | $27.22 | |
| Cash Flow / Share | $8.54 | $7.35 | $7.54 | $6.45 | $7.13 | $5.82 | $7.67 | $8.59 | $7.77 | $8.06 | $4.30 | $6.13 | |
| Cash / Share | $1.86 | $1.66 | $1.31 | $1.20 | $1.53 | $2.58 | $1.99 | $1.76 | $1.71 | $2.08 | $4.82 | · | |
| Dividend / Share | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.88 | $0.88 | |
| EPS (TTM) | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 | $-0.67 | $5.47 | $-1.86 | $8.90 | $1.51 | $0.77 | $4.20 |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.2% | 3.9% | 6.6% | 1.7% | 11.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.9% | 4.0% | 6.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -19.9% | -9.2% | 343.6% | -42.4% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 47.8% | 32.4% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -22.0% | -11.7% | 342.5% | -42.4% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 45.0% | 31.1% | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | -0.84% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8.23B | $7.68B | $7.39B | $6.94B | $6.83B | $6.13B | $7.98B | $7.93B | $7.80B | $7.67B | $6.00B | $4.67B | |
| Net Income TTM | $705M | $904M | $1.02B | $231M | $402M | $-139M | $1.13B | $-379M | $1.81B | $306M | $147M | $720M | |
| Market Cap | $28.66B | $33.54B | $38.48B | $40.01B | $38.58B | $46.59B | $45.03B | $31.01B | $35.91B | $30.53B | $30.15B | · | |
| Enterprise Value | $35.58B | $39.22B | $43.83B | $45.33B | $45.17B | $53.91B | $52.64B | $39.40B | $45.53B | $41.14B | $40.25B | · | |
| P/E | 25.3 | 23.8 | 24.9 | 115.9 | 64.6 | -223.3 | 26.6 | -54.1 | 13.2 | 66.4 | 129.4 | 26.2 | |
| P/S | 3.5 | 4.4 | 5.2 | 5.8 | 5.7 | 7.6 | 5.6 | 3.9 | 4.6 | 4.0 | 5.0 | · | |
| P/B | 2.3 | 2.7 | 3.1 | 3.3 | 3.0 | 3.8 | 3.6 | 2.8 | 3.1 | 3.2 | 3.0 | · | |
| P / Cash Flow | 16.9 | 22.4 | 24.3 | 29.5 | 25.7 | 38.7 | 28.4 | 17.7 | 22.7 | 18.7 | 36.9 | · | |
| P / FCF | 19.5 | 25.9 | 29.8 | 34.2 | 29.1 | 42.9 | 32.7 | 19.6 | 25.2 | 21.1 | 46.5 | · | |
| EV / EBITDA | 16.2 | 17.2 | 19.7 | 27.9 | 24.4 | 57.1 | 24.6 | 36.7 | 24.3 | 22.1 | 34.1 | · | |
| EV / FCF | 24.2 | 30.3 | 34.0 | 38.8 | 34.0 | 49.6 | 38.2 | 24.9 | 31.9 | 28.4 | 62.0 | · | |
| EV / Revenue | 4.3 | 5.1 | 5.9 | 6.5 | 6.6 | 8.8 | 6.6 | 5.0 | 5.8 | 5.4 | 6.7 | · | |
| Dividend Yield | 0.66% | 0.58% | 0.52% | 0.50% | 0.52% | 0.43% | 0.44% | 0.63% | 0.54% | 0.62% | 0.52% | · | |
| Earnings Yield | 4.0% | 4.2% | 4.0% | 0.86% | 1.6% | -0.45% | 3.8% | -1.8% | 7.6% | 1.5% | 0.77% | 3.8% | |
| Payout Ratio | 27.0% | 21.7% | 19.6% | 87.0% | 49.8% | -142.9% | 17.4% | -51.5% | 10.7% | 61.6% | 106.9% | 20.2% | |
| Annual Payout | $190M | $196M | $201M | $201M | $200M | $198M | $197M | $195M | $194M | $188M | $157M | $146M |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.18B | $2.09B | $2.24B | $2.00B | $2.08B | $1.91B | $2.02B | $1.82B | $1.94B | $1.89B | $1.94B | $1.75B | $1.87B | $1.83B | $1.83B | $1.67B | |
| Cost of Revenue | $636M | $576M | $792M | $559M | $592M | $550M | $587M | $539M | $554M | $512M | $539M | $519M | $526M | $501M | $520M | $488M | |
| SG&A Expense | $899M | $850M | $872M | $811M | $815M | $759M | $747M | $710M | $737M | $736M | $722M | $675M | $726M | $716M | $727M | $655M | |
| Operating Expenses | $1.85B | $1.71B | $2.09B | $1.65B | $1.78B | $1.62B | $1.63B | $1.54B | $1.59B | $1.62B | $1.59B | $1.49B | $1.54B | $1.50B | $1.85B | $1.42B | |
| Operating Income | $326M | $373M | $154M | $351M | $300M | $292M | $389M | $280M | $351M | $266M | $354M | $267M | $330M | $327M | $-28M | $245M | |
| Other Non-op | $2M | $-3M | $15M | $3M | $4M | $3M | $-38M | $5M | $2M | $-100.0K | $-20M | $4M | $-1M | $8M | $-4M | $-25M | |
| Pretax Income | $255M | $301M | $98M | $279M | $225M | $229M | $289M | $230M | $302M | $215M | $284M | $219M | $277M | $287M | $-75M | $178M | |
| Income Tax | $56M | $63M | $-40M | $48M | $71M | $46M | $49M | $-19M | $59M | $42M | $-135M | $56M | $67M | $54M | $55M | $-17M | |
| Net Income | $198M | $238M | $139M | $231M | $153M | $182M | $240M | $249M | $243M | $172M | $419M | $163M | $210M | $232M | $-130M | $194M | |
| EPS (Basic) | $1.03 | $1.22 | $0.70 | $1.17 | $0.77 | $0.92 | $1.20 | $1.23 | $1.18 | $0.84 | $2.02 | $0.78 | $1.00 | $1.11 | $-0.62 | $0.92 | |
| EPS (Diluted) | $1.03 | $1.22 | $0.71 | $1.16 | $0.77 | $0.91 | $1.18 | $1.23 | $1.18 | $0.84 | $2.00 | $0.77 | $1.00 | $1.11 | $-0.62 | $0.92 | |
| Shares (Basic) | 192,200,000 | 195,000,000 | · | 198,100,000 | 197,900,000 | 198,900,000 | · | 202,300,000 | 205,700,000 | 205,200,000 | · | 208,900,000 | 208,600,000 | 209,400,000 | · | 209,800,000 | |
| Shares (Diluted) | 192,800,000 | 195,800,000 | · | 198,800,000 | 198,300,000 | 199,700,000 | · | 203,000,000 | 206,400,000 | 206,200,000 | · | 210,000,000 | 209,900,000 | 210,400,000 | · | 210,300,000 | |
| EBITDA | $326M | $643M | · | $351M | $300M | $547M | · | $280M | $351M | $504M | · | $267M | $330M | $559M | · | $245M |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $410M | $424M | $592M | $1.29B | $557M | $1.38B | $526M | $569M | $420M | $393M | · | $292M | $320M | $330M | · | $545M | |
| Receivables | $1.77B | $1.73B | $1.70B | $1.60B | $1.61B | $1.53B | $1.48B | $1.48B | $1.42B | $1.45B | · | $1.34B | $1.37B | $1.38B | · | $1.28B | |
| Inventory | $2.27B | $2.25B | $2.29B | $2.48B | $2.45B | $2.24B | $2.24B | $2.37B | $2.37B | $2.39B | · | $2.32B | $2.28B | $2.24B | · | $2.13B | |
| Prepaid Expense | $647M | $563M | $537M | $460M | $431M | $428M | $430M | $445M | $431M | $404M | · | $416M | $425M | $460M | · | $347M | |
| Current Assets | $5.10B | $4.96B | $5.12B | $5.83B | $5.05B | $5.59B | $4.67B | $4.86B | $4.64B | $4.63B | · | $4.37B | $4.39B | $4.41B | · | $4.53B | |
| PP&E (Net) | $2.24B | $2.21B | $2.21B | $2.19B | $2.18B | $2.06B | $2.05B | $2.11B | $2.10B | $2.09B | · | $2.03B | $1.98B | $1.91B | · | $1.80B | |
| PP&E (Gross) | $7.42B | $7.30B | $7.26B | $7.22B | $7.15B | $6.82B | $6.69B | $6.90B | $6.74B | $6.85B | · | $6.65B | $6.72B | $6.59B | · | $6.34B | |
| Accum. Depreciation | $5.18B | $5.09B | $5.05B | $5.03B | $4.97B | $4.76B | $4.64B | $4.79B | $4.64B | $4.76B | · | $4.61B | $4.74B | $4.69B | · | $4.54B | |
| Goodwill | $9.92B | $9.93B | $9.95B | $9.70B | $9.71B | $8.99B | $8.95B | $8.91B | $8.82B | $8.79B | $8.82B | $8.71B | $8.74B | $8.73B | $8.58B | $8.80B | |
| Intangibles | $4.46B | $4.55B | $4.72B | $4.74B | $4.89B | $4.47B | $4.60B | $4.67B | $4.71B | $4.73B | · | $4.89B | $5.03B | $5.07B | · | $5.14B | |
| Other Non-current Assets | $1.08B | $1.07B | $1.10B | $1.02B | $1.04B | $1.07B | $1.10B | $1.17B | $1.25B | $1.20B | · | $1.21B | $1.16B | $1.12B | · | $1.06B | |
| Total Assets | $22.80B | $22.72B | $23.09B | $23.49B | $22.87B | $22.18B | $21.37B | $21.72B | $21.52B | $21.45B | · | $21.22B | $21.29B | $21.24B | · | $21.33B | |
| Accounts Payable | $352M | $361M | $303M | $315M | $349M | $301M | $195M | $322M | $342M | $370M | · | $320M | $355M | $397M | · | $334M | |
| Accrued Liabilities | · | · | $834M | · | · | · | $706M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $3.01B | $2.86B | $2.58B | $2.40B | $2.70B | $2.29B | $2.45B | $3.57B | $3.61B | $2.80B | · | $2.07B | $2.23B | $2.34B | · | $2.30B | |
| Capital Leases | · | · | $176M | · | · | · | $190M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $236M | $250M | $244M | · | · | · | $352M | · | · | $370M | · | $465M | $475M | $485M | · | $541M | |
| Other Non-current Liabilities | $639M | $631M | $626M | $806M | $879M | $909M | $744M | $1.03B | $1.21B | $577M | · | $632M | $642M | $637M | · | $609M | |
| Total Liabilities | $10.17B | $10.04B | $10.39B | $10.72B | $10.33B | $9.78B | $8.89B | $9.34B | $8.77B | $8.85B | · | $8.70B | $8.92B | $9.09B | · | $9.08B | |
| Long-term Debt | $7.48B | $7.47B | $7.52B | $8.11B | $7.57B | $7.18B | $6.20B | $6.45B | $5.83B | $5.80B | · | $5.48B | $5.71B | $5.79B | · | $5.71B | |
| Total Debt | $7.48B | $7.47B | · | $8.11B | $7.57B | $7.18B | · | $6.45B | $5.83B | $5.80B | · | $5.48B | $5.71B | $5.79B | · | $5.71B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Retained Earnings | $11.96B | $11.80B | $11.61B | $11.52B | $11.34B | $11.23B | $11.10B | $10.90B | $10.70B | $10.51B | · | $10.01B | $9.90B | $9.74B | · | $9.74B | |
| Treasury Stock | $9.39B | $9.14B | $8.89B | $8.64B | $8.64B | $8.64B | $8.41B | $8.35B | $7.74B | $7.65B | · | $7.12B | $7.12B | $7.11B | · | $6.72B | |
| AOCI | $-164M | $-190M | $-206M | $-284M | $-284M | $-287M | $-263M | $-202M | $-195M | $-211M | · | $-186M | $-178M | $-178M | · | $-245M | |
| Stockholders' Equity | $12.62B | $12.67B | $12.70B | $12.76B | $12.53B | $12.40B | $12.47B | $12.37B | $12.74B | $12.60B | · | $12.51B | $12.37B | $12.15B | · | $12.24B | |
| Liabilities + Equity | $22.80B | $22.72B | $23.09B | $23.49B | $22.87B | $22.18B | $21.37B | $21.72B | $21.52B | $21.45B | · | $21.22B | $21.29B | $21.24B | · | $21.33B | |
| Shares Outstanding | 319,400,000 | 319,300,000 | 318,700,000 | 318,700,000 | 318,400,000 | 318,400,000 | 317,500,000 | 317,400,000 | 317,200,000 | 317,200,000 | 316,200,000 | 316,000,000 | 315,800,000 | 315,400,000 | 313,800,000 | 313,600,000 |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $271M | $270M | $284M | $284M | $272M | $254M | $264M | $251M | $243M | $239M | $241M | $241M | $238M | $232M | $228M | $231M | |
| Stock-based Comp | $25M | $24M | $24M | $25M | $21M | $20M | $21M | $24M | $26M | $29M | $25M | $16M | $34M | $25M | $27M | $27M | |
| Amort. of Intangibles | $163M | $162M | $178M | $176M | $161M | $151M | $158M | $148M | $144M | $142M | $145M | $145M | $138M | $133M | $132M | $132M | |
| Other Non-cash | · | $-173M | · | · | · | $-73M | · | · | · | $-212M | · | · | · | $-182M | · | · | |
| Operating Cash Flow | $448M | $359M | $517M | $419M | $378M | $383M | $506M | $396M | $369M | $228M | $588M | $338M | $348M | $308M | $244M | $451M | |
| CapEx | $54M | $36M | $75M | $55M | $50M | $45M | $52M | $44M | $53M | $55M | $63M | $84M | $97M | $47M | $63M | $47M | |
| Investing Cash Flow | $-191M | $-159M | $-322M | $-163M | $-1.38B | $-106M | $-291M | $-155M | $-247M | $-195M | $-221M | $-166M | $-243M | $-149M | · | · | |
| Stock Repurchased | $251M | $250M | $250M | $0 | $7M | $230M | $72M | $596M | $86M | $114M | $410M | $0 | $14M | $268M | · | · | |
| Net Stock Activity | · | $-250M | · | · | · | $-230M | · | · | · | $-114M | · | · | · | $-268M | · | · | |
| Dividends Paid | $46M | $47M | $48M | $48M | $48M | $48M | $48M | $49M | $49M | $49M | $50M | $50M | $50M | $50M | $50M | $50M | |
| Financing Cash Flow | $-271M | $-369M | $-897M | $484M | $164M | $575M | $-241M | $-102M | $-92M | $-50M | $-251M | $-196M | $-109M | $-207M | · | · | |
| Net Change in Cash | $-14M | $-168M | $-701M | $736M | $-828M | $859M | $-44M | $149M | $27M | $-23M | $124M | $-28M | $-10M | $-46M | $-170M | $159M | |
| Free Cash Flow | · | $323M | · | · | · | $338M | · | · | · | $173M | · | · | · | $261M | · | · |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.0% | 17.9% | · | 17.5% | 14.4% | 15.3% | · | 15.3% | 18.1% | 14.1% | · | 15.2% | 17.6% | 17.9% | · | 14.7% | |
| Net Margin | 9.1% | 11.4% | · | 11.5% | 7.4% | 9.5% | · | 13.7% | 12.5% | 9.1% | · | 9.3% | 11.2% | 12.7% | · | 11.6% | |
| Pretax Margin | 11.7% | 14.4% | · | 14.0% | 10.8% | 12.0% | · | 12.6% | 15.6% | 11.4% | · | 12.5% | 14.8% | 15.7% | · | 10.6% | |
| EBITDA Margin | 15.0% | 30.8% | · | 17.5% | 14.4% | 28.6% | · | 15.3% | 18.1% | 26.7% | · | 15.2% | 17.6% | 30.5% | · | 14.7% | |
| ROA | 0.87% | 1.1% | · | 1.0% | 0.69% | 0.83% | · | 1.2% | 1.1% | 0.81% | · | 0.76% | 0.98% | 1.1% | · | 0.86% | |
| ROE | 1.6% | 1.9% | · | 1.8% | 1.2% | 1.5% | · | 2.0% | 1.9% | 1.4% | · | 1.3% | 1.7% | 1.9% | · | 1.6% | |
| ROIC | 1.3% | 1.5% | · | 1.4% | 1.0% | 1.2% | · | 1.6% | 1.5% | 1.2% | · | 1.1% | 1.4% | 1.5% | · | 1.5% |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.7 | · | 2.4 | 1.9 | 2.4 | · | 1.4 | 1.3 | 1.7 | · | 2.1 | 2.0 | 1.9 | · | 2.0 | |
| Quick Ratio | 0.7 | 0.8 | · | 1.2 | 0.8 | 1.3 | · | 0.6 | 0.5 | 0.7 | · | 0.8 | 0.8 | 0.7 | · | 0.8 | |
| Debt / Equity | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.6 | 0.5 | 0.5 | · | 0.4 | 0.3 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.3 | 1.4 | 1.3 | · | 1.3 | 1.4 | 1.3 | · | 1.3 | 1.4 | 1.4 | · | 1.3 |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $39.52 | $39.69 | · | $40.03 | $39.34 | $38.93 | · | $38.99 | $40.17 | $39.72 | · | $39.59 | $39.18 | $38.52 | · | $39.05 | |
| Revenue / Share | $11.29 | $10.66 | · | $10.07 | $10.48 | $9.56 | · | $8.99 | $9.41 | $9.16 | · | $8.35 | $8.91 | $8.70 | · | $7.94 | |
| Cash Flow / Share | · | $1.84 | · | · | · | $1.92 | · | · | · | $1.11 | · | · | · | $1.46 | · | · | |
| Cash / Share | $1.28 | $1.33 | · | $4.06 | $1.75 | $4.35 | · | $1.79 | $1.32 | $1.24 | · | $0.92 | $1.01 | $1.05 | · | $1.74 | |
| Dividend / Share | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | |
| EPS (TTM) | $4.12 | $3.86 | · | $4.02 | $4.09 | $4.50 | · | $5.25 | $4.79 | $4.61 | · | $2.26 | $2.41 | $2.14 | · | $1.33 |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8.51B | $8.41B | · | $8.01B | $7.83B | $7.70B | · | $7.60B | $7.52B | $7.45B | · | $7.28B | $7.20B | $7.11B | · | $6.89B | |
| Net Income TTM | $807M | $761M | · | $805M | $823M | $913M | · | $1.08B | $997M | $964M | · | $474M | $506M | $450M | · | $278M | |
| Market Cap | $27.50B | $28.87B | · | $31.39B | $29.04B | $36.04B | · | $34.26B | $34.43B | $41.86B | · | $35.46B | $45.98B | $40.75B | · | $32.79B | |
| Enterprise Value | $34.57B | $35.92B | · | $38.21B | $36.06B | $41.83B | · | $40.15B | $39.84B | $47.27B | · | $40.65B | $51.37B | $46.21B | · | $37.96B | |
| P/E | 20.9 | 23.4 | · | 24.5 | 22.3 | 25.2 | · | 20.6 | 22.7 | 28.6 | · | 49.7 | 60.4 | 60.4 | · | 78.6 | |
| P/S | 3.2 | 3.4 | · | 3.9 | 3.7 | 4.7 | · | 4.5 | 4.6 | 5.6 | · | 4.9 | 6.4 | 5.7 | · | 4.8 | |
| P/B | 2.2 | 2.3 | · | 2.5 | 2.3 | 2.9 | · | 2.8 | 2.7 | 3.3 | · | 2.8 | 3.7 | 3.4 | · | 2.7 | |
| P / Cash Flow | · | 80.3 | · | · | · | 94.1 | · | · | · | 183.6 | · | · | · | 132.4 | · | · | |
| EV / Revenue | 4.1 | 4.3 | · | 4.8 | 4.6 | 5.4 | · | 5.3 | 5.3 | 6.3 | · | 5.6 | 7.1 | 6.5 | · | 5.5 | |
| Dividend Yield | 0.69% | 0.66% | · | 0.61% | 0.66% | 0.54% | · | 0.58% | 0.58% | 0.48% | · | 0.57% | 0.44% | 0.49% | · | 0.61% | |
| Earnings Yield | 4.8% | 4.3% | · | 4.1% | 4.5% | 4.0% | · | 4.9% | 4.4% | 3.5% | · | 2.0% | 1.7% | 1.7% | · | 1.3% | |
| Payout Ratio | · | 19.7% | · | · | · | 26.3% | · | · | · | 28.6% | · | · | · | 21.6% | · | · | |
| Annual Payout | $188M | $189M | · | $191M | $192M | $194M | · | $198M | $199M | $200M | · | $201M | $201M | $201M | · | $201M |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $8.23B | $7.68B | $7.39B | $6.94B | $6.83B |
| Margem Operacional % | 13.3% | 16.7% | 17.3% | 10.0% | 10.0% |
| Lucro líquido | $705M | $904M | $1.02B | $231M | $402M |
| EPS Diluído | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 |
| Índice de liquidez corrente | 2.0 | 1.9 | 1.6 | 1.9 | 1.4 |
| Índice de Liquidez Seca | 0.9 | 0.8 | 0.7 | 0.7 | 0.5 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $1.47B | $1.30B | $1.29B | $1.17B | $1.33B |
Investidores institucionais (13F) 976 declarantes · $18.6B total · Em 30 de Setembro de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Detentores
976
Valor detido
$18.6B
Novas posições
89
Posições encerradas
81
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 89 (-27 vs trimestre anterior) | 81 (-21 vs trimestre anterior) | 313 (+13 vs trimestre anterior) | 303 (+4 vs trimestre anterior) | +9.4M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $2.111.657.991 | 23.483.741 | 11,35% | Ações |
| Dodge & Cox | $2.076.898.436 | 24.124.735 | 11,17% | Ações |
| BlackRock, Inc. | $1.344.282.175 | 15.614.847 | 7,23% | Ações |
| HARRIS ASSOCIATES L P | $1.096.616.595 | 12.738.025 | 5,90% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.087.741.726 | 12.634.937 | 5,85% | Ações |
| Capital International Investors | $1.048.887.329 | 12.183.614 | 5,64% | Ações |
| STATE STREET CORP | $766.342.640 | 8.877.171 | 4,12% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $726.749.999 | 8.441.747 | 3,91% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $458.747.478 | 5.349.223 | 2,47% | Ações |
| Invesco Ltd. | $342.626.146 | 3.979.860 | 1,84% | Ações |
| PRIMECAP MANAGEMENT CO/CA/ | $328.577.983 | 3.816.680 | 1,77% | Ações |
| VAN ECK ASSOCIATES CORP | $301.457.394 | 3.501.654 | 1,62% | Ações |
| CITADEL ADVISORS LLC | $299.375.565 | 3.477.472 | 1,61% | Ações |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $237.731.423 | 2.761.429 | 1,28% | Ações |
| UBS Group AG | $237.489.165 | 2.758.615 | 1,28% | Ações |
| AMERICAN CENTURY COMPANIES INC | $236.270.951 | 2.744.463 | 1,27% | Ações |
| MORGAN STANLEY | $223.102.705 | 2.591.503 | 1,20% | Ações |
| BANK OF AMERICA CORP /DE/ | $187.480.282 | 2.177.724 | 1,01% | Ações |
| NORTHERN TRUST CORP | $169.171.326 | 1.965.052 | 0,91% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $168.672.488 | 1.958.313 | 0,91% | Ações |
| EQUITY INVESTMENT CORP | $144.748.296 | 1.681.360 | 0,78% | Ações |
| NORGES BANK | $136.661.935 | 1.587.431 | 0,73% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $134.484.547 | 1.562.139 | 0,72% | Ações |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $132.937.293 | 1.470.220 | 0,71% | Ações |
| Legal & General Group Plc | $126.167.392 | 1.465.529 | 0,68% | Ações |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $125.541.517 | 1.458.259 | 0,67% | Ações |
| Vestal Point Capital, LP | $120.526.000 | 1.400.000 | 0,65% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $118.554.797 | 1.377.103 | 0,64% | Ações |
| Holocene Advisors, LP | $101.367.617 | 1.177.461 | 0,54% | Ações |
| VICTORY CAPITAL MANAGEMENT INC | $99.065.937 | 1.150.725 | 0,53% | Ações |
| Bank of New York Mellon Corp | $95.820.351 | 1.113.025 | 0,52% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $93.508.375 | 1.086.170 | 0,50% | Ações |
| Camber Capital Management LP | $91.210.000 | 1.000.000 | 0,49% | Ações |
| AMERIPRISE FINANCIAL INC | $89.620.025 | 1.040.975 | 0,48% | Ações |
| GOLDMAN SACHS GROUP INC | $83.389.162 | 968.628 | 0,45% | Ações |
| TORONTO DOMINION BANK | $81.590.162 | 947.731 | 0,44% | Ações |
| Woodline Partners LP | $81.122.607 | 942.300 | 0,44% | Ações |
| DEUTSCHE BANK AG\ | $79.508.592 | 923.552 | 0,43% | Ações |
| Point72 Asset Management, L.P. | $75.746.373 | 879.851 | 0,41% | Ações |
| RAYMOND JAMES FINANCIAL INC | $74.568.500 | 866.170 | 0,40% | Ações |
| JPMORGAN CHASE & CO | $74.444.065 | 815.914 | 0,40% | Ações |
| Sound Shore Management Inc /CT/ | $68.407.286 | 794.602 | 0,37% | Ações |
| CAUSEWAY CAPITAL MANAGEMENT LLC | $67.908.650 | 788.810 | 0,37% | Ações |
| Quantinno Capital Management LP | $62.169.005 | 722.139 | 0,33% | Ações |
| Amundi | $61.922.729 | 719.279 | 0,33% | Ações |
| Boston Partners | $61.088.392 | 709.202 | 0,33% | Ações |
| Meridiem Capital Partners LP | $54.973.200 | 638.555 | 0,30% | Ações |
| SHAPIRO CAPITAL MANAGEMENT LLC | $52.119.833 | 605.411 | 0,28% | Ações |
| BANK OF MONTREAL /CAN/ | $49.368.266 | 573.449 | 0,27% | Ações |
| Magellan Asset Management Ltd | $49.106.511 | 570.409 | 0,26% | Ações |
Ativistas e proprietários de 5%+ 6 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings, Inc., Honey Badger Merger Sub, Inc. | 15 de Julho de 2025 | 27,00% | Declaração inicial | M&A / venda | SEC |
| KKR Biomet LLC, KKR 2006 Fund L.P., OPERF Co-Investment LLC, KKR PEI Investments, L.P., 8 North America Investor L.P., KKR Partners III, L.P., KKR Associates 2006 LP, KKR 2006 GP LLC, KKR PEI Associates, L.P., KKR PEI GP Limited, KKR Associates 8 NA L.P., KKR 8 NA Limited, KKR III GP LLC, KKR Fund Holdings L.P., KKR Fund Holdings GP Limited, KKR Group Holdings L.P., KKR Group Limited, KKR & Co. L.P., KKR Management LLC, Henry R. Kravis, George R. Roberts ×3 declarações | 16 de Junho de 2016 | · | Declaração inicial | · | SEC |
| TPG Group Holdings (SBS) Advisors, Inc., David Bonderman, James G. Coulter ×3 declarações | 16 de Junho de 2016 | · | Declaração inicial | Estrutura de capital | SEC |
| Blackstone Capital Partners V, L.P., Blackstone Capital Partners V-AC L.P., BCP V-S L.P., Blackstone Family Investment Partnership V L.P., Blackstone Family Investment Partnership V-SMD L.P., Blackstone Participation Partnership V L.P., BCP V Co-Investors L.P., Blackstone Management Associates V L.L.C., BMA V L.L.C., BCP V Side-By-Side GP L.L.C., Blackstone Family GP L.L.C., Blackstone Holdings III L.P., Blackstone Holdings III GP L.P., Blackstone Holdings III GP Management L.L.C., The Blackstone Group L.P., Blackstone Group Management L.L.C., Stephen A. Schwarzman ×3 declarações | 12 de Fevereiro de 2016 | · | Declaração inicial | · | SEC |
| LVB Acquisition Holding, LLC ×2 declarações | 9 de Fevereiro de 2016 | · | Declaração inicial | · | SEC |
| Zimmer Holdings, Inc., Zimmer, Inc., Zimmer CEP USA Holding Co. ×3 declarações | 10 de Agosto de 2006 | · | Declaração inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Executivos da empresa 62 insiders · 38 diretores · 24 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Ivan Tornos | Chairman, President and CEO | 6 de Março de 2026 M | 83.191 | 0 | 0 | $0 |
| Bryan C Hanson | President and CEO | 6 de Março de 2023 A | 102.797 | 0 | 0 | $0 |
| John Raymond Elliott | Chairman, Pres. & CEO | 12 de Fevereiro de 2007 M | 62.751 | 0 | 0 | $0 |
| Suketu Upadhyay | Exec VP, CFO | 6 de Março de 2026 M | 69.485 | 0 | 0 | $0 |
| Florin Daniel P | Exec. VP, CFO | 8 de Maio de 2019 G | 25.471 | 0 | 0 | $0 |
| James T Crines | EVP, Finance and CFO | 19 de Março de 2015 M | 56.313 | 0 | 0 | $0 |
| Chintan Desai | President, APAC | 3 de Agosto de 2026 A | · | 0 | 0 | $0 |
| Sang Yi | Group President, Asia Pacific | 29 de Maio de 2026 S | 27.251 | 0 | 3 | $-509.706 |
| Mark Bezjak | President, Americas | 6 de Março de 2025 M | 13.134 | 0 | 0 | $0 |
| Didier Deltort | President, EMEA | 26 de Fevereiro de 2021 M | 4.619 | 0 | 0 | $0 |
| Aure Bruneau | Group President | 11 de Novembro de 2019 M | 757 | 0 | 0 | $0 |
| Robert D. Delp | President, Americas | 20 de Março de 2018 A | · | 0 | 0 | $0 |
| David A. Nolan Jr. | Group President | 20 de Março de 2018 A | 9.102 | 0 | 0 | $0 |
| Daniel E. Williamson | Group President | 20 de Março de 2018 A | 2.000 | 0 | 0 | $0 |
| Adam Rudolph Johnson | Group President | 24 de Junho de 2017 M | 11.093 | 0 | 0 | $0 |
| Stuart G. Kleopfer | President, Americas | 23 de Agosto de 2016 S | 3.000 | 0 | 0 | $0 |
| Stephen H L Ooi | President, Asia Pacific | 19 de Março de 2015 M | 45.411 | 0 | 0 | $0 |
| Joseph A. Cucolo | President, Americas | 1 de Outubro de 2014 M | 11.226 | 0 | 0 | $0 |
| Jon E Kramer | President, U.S. Sales | 12 de Dezembro de 2008 M | 4.461 | 0 | 0 | $0 |
| Kevin R Thornal | Grp Pres-Global Business | 11 de Setembro de 2026 S | 0 | 0 | 1 | $-528.978 |
| Chad F Phipps | Senior Vice President, Chief Legal & Corporate Affairs Officer and Secretary | 4 de Setembro de 2026 S | 65.231 | 0 | 1 | $-295.050 |
| Jehanzeb Noor | Senior Vice President, Chief Strategy, Innovation & Business Development Officer | 1 de Junho de 2026 A | 5.151 | 0 | 0 | $0 |
| Paul A Stellato | VP, Controller, CAO | 1 de Maio de 2026 A | 5.582 | 0 | 0 | $0 |
| Lori Winkler | SVP and CHRO | 12 de Março de 2026 S | 10.224 | 0 | 1 | $-250.849 |
| Wilfred Van Zuilen | Group Pres, EMEA | 6 de Março de 2026 M | 30.991 | 0 | 0 | $0 |
| Rachel Ellingson | Chief Administrative Officer | 20 de Fevereiro de 2025 M | 11.906 | 0 | 0 | $0 |
| Derek M Davis | Interim Controller & CAO | 1 de Março de 2022 A | 6.809 | 0 | 0 | $0 |
| Carrie Ann Nichol | VP, Controller & CAO | 1 de Outubro de 2021 M | 338 | 0 | 0 | $0 |
| Tony W. Collins | VP, Controller and CAO | 31 de Julho de 2018 M | 368 | 0 | 0 | $0 |
| Katarzyna Mazur-Hofsaess | Pres., Eur., M. East & Afr. | 22 de Maio de 2018 M | 16.682 | 0 | 0 | $0 |
| Jeffery A Mccaulley | Pres - Zimmer Reconstructive | 8 de Janeiro de 2014 M | 5.211 | 0 | 0 | $0 |
| Jeffrey B Paulsen | Group Pres., Global Businesses | 16 de Março de 2013 M | 6.095 | 0 | 0 | $0 |
| Cheryl R Blanchard | Sr. VP, Chief Scientific Off. | 19 de Março de 2012 A | 18.357 | 0 | 0 | $0 |
| Mark C Throdahl | Group Pres - Global Business | 12 de Junho de 2009 D | 844 | 0 | 0 | $0 |
| Sheryl L Conley | Group Pres., Americas & Mktg. | 12 de Fevereiro de 2008 A | 2.559 | 0 | 0 | $0 |
| Sam R Leno | EVP | 4 de Maio de 2007 D | 27.513 | 0 | 0 | $0 |
| Richard Fritschi | Pres. Zimmer Europe & Austral. | 18 de Janeiro de 2005 A | · | 0 | 0 | $0 |
| Bruce Edward Peterson | Chairman, Zimmer Americas | 17 de Março de 2004 M | 17.975 | 0 | 0 | $0 |
| Louis Shapiro | Conselheiro | 30 de Setembro de 2026 A | · | 0 | 0 | $0 |
| Devdatt Kurdikar | Conselheiro | 30 de Setembro de 2026 A | · | 0 | 0 | $0 |
| Sreelakshmi Kolli | Conselheiro | 30 de Setembro de 2026 A | 1.000 | 0 | 0 | $0 |
| Maria Teresa Hilado | Conselheiro | 30 de Setembro de 2026 A | 1.650 | 0 | 0 | $0 |
| Michael J. Farrell | Conselheiro | 30 de Setembro de 2026 A | 2.000 | 0 | 0 | $0 |
| Robert Hagemann | Conselheiro | 30 de Setembro de 2026 A | 4.000 | 0 | 0 | $0 |
| HIGGINS ARTHUR J | Conselheiro | 30 de Setembro de 2026 A | 3.400 | 0 | 0 | $0 |
| Syed A. Jafry | Conselheiro | 22 de Maio de 2026 A | 4.060 | 0 | 0 | $0 |
| Betsy J Bernard | Conselheiro | 22 de Maio de 2026 A | 5.271 | 0 | 0 | $0 |
| Christopher B Begley | Conselheiro | 31 de Março de 2025 A | 3.540 | 0 | 0 | $0 |
| Michael W Michelson | Conselheiro | 10 de Maio de 2024 A | 3.385 | 0 | 0 | $0 |
| Gail Boudreaux | Conselheiro | 31 de Março de 2021 A | 2.095 | 0 | 0 | $0 |
| Larry C Glasscock | Conselheiro | 8 de Maio de 2020 A | 10.861 | 0 | 0 | $0 |
| Jeffrey K. Rhodes | Conselheiro | 31 de Março de 2018 A | · | 0 | 0 | $0 |
| Cecil B Pickett | Conselheiro | 12 de Maio de 2017 A | · | 0 | 0 | $0 |
| Paul Bisaro | Conselheiro | 31 de Março de 2017 A | · | 0 | 0 | $0 |
| John L Mcgoldrick | Conselheiro | 7 de Maio de 2013 A | 11.332 | 0 | 0 | $0 |
| Marc N Casper | Conselheiro | 31 de Março de 2013 A | · | 0 | 0 | $0 |
| Augustus A White | Conselheiro | 3 de Maio de 2010 A | 0 | 0 | 0 | $0 |
| Stuart Essig | Conselheiro | 5 de Maio de 2008 A | · | 0 | 0 | $0 |
| Regina E Herzlinger | Conselheiro | 2 de Maio de 2005 A | 40 | 0 | 0 | $0 |
| David C Dvorak | · | 27 de Abril de 2017 M | 294.555 | 0 | 0 | $0 |
| LVB Acquisition Holding, LLC | · | 4 de Fevereiro de 2016 J | 0 | 0 | 0 | $0 |
| Bruno A Melzi | · | 16 de Março de 2013 M | 11.005 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 119 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| IHI · iShares Trust | 2,69% | 924.883 SH | 11 de Setembro de 2026 | Diário |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,47% | 275.654 NS | 31 de Julho de 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,54% | 152.036 SH | 2 de Outubro de 2026 | Diário |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,94% | 139.642 NS | 31 de Julho de 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 0,94% | 4.287 NS | 31 de Julho de 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,49% | 81.838 NS | 31 de Julho de 2026 | N-PORT |
| UPSD · ETF Series Solutions | 0,47% | 5.916 NS | 31 de Julho de 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,47% | 8.435 NS | 31 de Julho de 2026 | N-PORT |
| SOVF · Elevation Series Trust | 0,41% | 3.781 NS | 31 de Julho de 2026 | N-PORT |
| NUDV · Nushares ETF Trust | 0,40% | 2.152 NS | 31 de Julho de 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0,34% | 64.683 SH | 2 de Outubro de 2026 | Diário |
| IYH · iShares Trust | 0,29% | 113.463 SH | 11 de Setembro de 2026 | Diário |
| FHLC · FIDELITY COVINGTON TRUST | 0,26% | 91.889 NS | 31 de Julho de 2026 | N-PORT |
| IMCV · iShares Trust | 0,25% | 31.505 SH | 11 de Setembro de 2026 | Diário |
| VHT · VANGUARD WORLD FUND | 0,25% | 581.880 SH | 19 de Agosto de 2026 | Diário |
| REVS · Columbia ETF Trust I | 0,24% | 8.508 NS | 31 de Julho de 2026 | N-PORT |
| IXJ · iShares Trust | 0,23% | 101.995 SH | 11 de Setembro de 2026 | Diário |
| SIZE · iShares Trust | 0,21% | 9.696 SH | 11 de Setembro de 2026 | Diário |
| CURE · Direxion Shares ETF Trust | 0,21% | 3.807 NS | 31 de Julho de 2026 | N-PORT |
| EQIN · Columbia ETF Trust I | 0,19% | 6.205 NS | 31 de Julho de 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,19% | 2.063.000 SH | 2 de Outubro de 2026 | Diário |
| EUSA · iShares, Inc. | 0,19% | 38.732 SH | 11 de Setembro de 2026 | Diário |
| VLUE · iShares Trust | 0,18% | 191.362 SH | 11 de Setembro de 2026 | Diário |
| VBR · VANGUARD INDEX FUNDS | 0,18% | 1.408.631 SH | 19 de Agosto de 2026 | Diário |
| IWS · iShares Trust | 0,18% | 289.171 SH | 11 de Setembro de 2026 | Diário |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,16% | 220.000 | 2 de Outubro de 2026 | Diário |
| RECS · Columbia ETF Trust I | 0,16% | 96.586 NS | 31 de Julho de 2026 | N-PORT |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 13.402 NS | 31 de Julho de 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,15% | 15.020 SH | 19 de Agosto de 2026 | Diário |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,15% | 4.099.000 | 2 de Outubro de 2026 | Diário |
| VOE · VANGUARD INDEX FUNDS | 0,14% | 621.372 SH | 19 de Agosto de 2026 | Diário |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,14% | 6.247.000 | 1 de Outubro de 2026 | Diário |
| IWR · iShares Trust | 0,13% | 792.254 SH | 11 de Setembro de 2026 | Diário |
| IMCB · iShares Trust | 0,12% | 22.655 SH | 11 de Setembro de 2026 | Diário |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,12% | 4.049.000 | 1 de Outubro de 2026 | Diário |
| XOEF · iShares Trust | 0,10% | 248 SH | 11 de Setembro de 2026 | Diário |
| VB · VANGUARD INDEX FUNDS | 0,10% | 2.218.373 SH | 19 de Agosto de 2026 | Diário |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 8.178 SH | 2 de Outubro de 2026 | Diário |
| CATH · Global X Funds | 0,09% | 11.989 NS | 31 de Julho de 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0,08% | 2.097.251 SH | 19 de Agosto de 2026 | Diário |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,08% | 8.286 SH | 2 de Outubro de 2026 | Diário |
| DFUV · Dimensional ETF Trust | 0,07% | 118.337 NS | 31 de Julho de 2026 | N-PORT |
| USXF · iShares Trust | 0,07% | 11.458 SH | 11 de Setembro de 2026 | Diário |
| PRF · Invesco Exchange-Traded Fund Trust | 0,06% | 70.147 SH | 2 de Outubro de 2026 | Diário |
| DFSU · Dimensional ETF Trust | 0,06% | 14.595 NS | 31 de Julho de 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,06% | 44.339 SH | 19 de Agosto de 2026 | Diário |
| IVE · iShares Trust | 0,06% | 321.014 SH | 11 de Setembro de 2026 | Diário |
| IUSV · iShares Trust | 0,06% | 168.895 SH | 11 de Setembro de 2026 | Diário |
| DXUV · Dimensional ETF Trust | 0,06% | 3.302 NS | 31 de Julho de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,06% | 284.411 NS | 31 de Julho de 2026 | N-PORT |
| IQSU · New York Life Investments ETF Trust | 0,06% | 1.943 NS | 31 de Julho de 2026 | N-PORT |
| CHRI · Global X Funds | 0,06% | 47 NS | 31 de Julho de 2026 | N-PORT |
| ILCV · iShares Trust | 0,05% | 7.599 SH | 11 de Setembro de 2026 | Diário |
| SUSL · iShares Trust | 0,05% | 6.763 SH | 11 de Setembro de 2026 | Diário |
| DSI · iShares Trust | 0,05% | 29.825 SH | 11 de Setembro de 2026 | Diário |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,05% | 116.793 SH | 19 de Agosto de 2026 | Diário |
| DCOR · Dimensional ETF Trust | 0,05% | 17.680 NS | 31 de Julho de 2026 | N-PORT |
| IWD · iShares Trust | 0,05% | 429.649 SH | 11 de Setembro de 2026 | Diário |
| EGLE · Global X Funds | 0,04% | 10 NS | 31 de Julho de 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0,04% | 5 NS | 31 de Julho de 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,04% | 44.794 SH | 2 de Outubro de 2026 | Diário |
| DFLV · Dimensional ETF Trust | 0,03% | 24.552 NS | 31 de Julho de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,03% | 45.016 NS | 31 de Julho de 2026 | N-PORT |
| XYLG · Global X Funds | 0,03% | 226 NS | 31 de Julho de 2026 | N-PORT |
| TOPC · iShares Trust | 0,03% | 117 SH | 11 de Setembro de 2026 | Diário |
| XCLR · Global X Funds | 0,03% | 12 NS | 31 de Julho de 2026 | N-PORT |
| XRMI · Global X Funds | 0,03% | 163 NS | 31 de Julho de 2026 | N-PORT |
| XVV · iShares Trust | 0,03% | 2.222 SH | 11 de Setembro de 2026 | Diário |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,03% | 5.778 SH | 2 de Outubro de 2026 | Diário |
| VOO · VANGUARD INDEX FUNDS | 0,03% | 5.022.961 SH | 19 de Agosto de 2026 | Diário |
| VTV · VANGUARD INDEX FUNDS | 0,03% | 920.066 SH | 19 de Agosto de 2026 | Diário |
| ESGV · VANGUARD WORLD FUND | 0,03% | 43.771 SH | 19 de Agosto de 2026 | Diário |
| TOV · EA Series Trust | 0,03% | 921 NS | 31 de Julho de 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,03% | 17.261 NS | 31 de Julho de 2026 | N-PORT |
| XYLD · Global X Funds | 0,03% | 10.147 NS | 31 de Julho de 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,03% | 10.046 NS | 31 de Julho de 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,03% | 26.677 NS | 31 de Julho de 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,03% | 3.273 NS | 31 de Julho de 2026 | N-PORT |
| ILCB · iShares Trust | 0,03% | 3.851 SH | 11 de Setembro de 2026 | Diário |
| DFUS · Dimensional ETF Trust | 0,03% | 60.829 NS | 31 de Julho de 2026 | N-PORT |
| IVV · iShares Trust | 0,03% | 2.438.768 SH | 11 de Setembro de 2026 | Diário |
| XTR · Global X Funds | 0,03% | 14 NS | 31 de Julho de 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0,03% | 1.142 SH | 2 de Outubro de 2026 | Diário |
| SPUU · Direxion Shares ETF Trust | 0,03% | 730 NS | 31 de Julho de 2026 | N-PORT |
| IYY · iShares Trust | 0,03% | 8.407 SH | 11 de Setembro de 2026 | Diário |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,03% | 33.488 SH | 2 de Outubro de 2026 | Diário |
| IWB · iShares Trust | 0,03% | 133.637 SH | 11 de Setembro de 2026 | Diário |
| QDPL · Pacer Funds Trust | 0,03% | 4.637 NS | 31 de Julho de 2026 | N-PORT |
| IWV · iShares Trust | 0,03% | 54.548 SH | 11 de Setembro de 2026 | Diário |
| USCL · iShares Trust | 0,03% | 7.635 SH | 11 de Setembro de 2026 | Diário |
| ITOT · iShares Trust | 0,02% | 251.793 SH | 11 de Setembro de 2026 | Diário |
| HCMT · Direxion Shares ETF Trust | 0,02% | 1.351 NS | 31 de Julho de 2026 | N-PORT |
| ACVF · ETF Opportunities Trust | 0,02% | 350 NS | 31 de Julho de 2026 | N-PORT |
| TOK · iShares Trust | 0,02% | 545 SH | 11 de Setembro de 2026 | Diário |
| SPXL · Direxion Shares ETF Trust | 0,02% | 15.123 NS | 31 de Julho de 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0,02% | 143 SH | 2 de Outubro de 2026 | Diário |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 6.142.505 SH | 19 de Agosto de 2026 | Diário |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 31.872 SH | 19 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 16.297 SH | 19 de Agosto de 2026 | Diário |
| URTH · iShares, Inc. | 0,02% | 17.242 SH | 11 de Setembro de 2026 | Diário |
| VOXP · Advisors Series Trust | 0,02% | 12 NS | 31 de Julho de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,02% | 4.266 NS | 31 de Julho de 2026 | N-PORT |
| ACWI · iShares Trust | 0,02% | 64.570 SH | 11 de Setembro de 2026 | Diário |
| DFAT · Dimensional ETF Trust | 0,02% | 23.873 NS | 31 de Julho de 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 5.624 SH | 2 de Outubro de 2026 | Diário |
| VV · VANGUARD INDEX FUNDS | 0,01% | 113.321 SH | 19 de Agosto de 2026 | Diário |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 168.446 SH | 19 de Agosto de 2026 | Diário |
| DYNF · BlackRock ETF Trust | 0,00% | 80 SH | 2 de Setembro de 2026 | Diário |
| FTLS · First Trust Exchange-Traded Fund III | -0,18% | -46.926 NS | 31 de Julho de 2026 | N-PORT |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 de Julho de 2026 | Diário |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 de Julho de 2026 | Diário |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 de Julho de 2026 | Diário |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 de Julho de 2026 | Diário |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 de Julho de 2026 | Diário |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 de Julho de 2026 | Diário |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 de Julho de 2026 | Diário |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 de Julho de 2026 | Diário |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 de Julho de 2026 | Diário |
| VCEB · VANGUARD WORLD FUND | · | · | 30 de Julho de 2026 | Diário |
ZBH Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
classificação · 33 analistas
MANTER
Alvo mediano
$106.00
+15,8%
3 9,1%
Compra forte
8 24,2%
Compra
22 66,7%
Manter
0 0,0%
Venda
0 0,0%
Venda forte
Preço-alvo de 12 meses
21 analistas · 2026-10-06Alvo médio $107.57 +17,5%
← Abaixo de todos os alvos
Preço atual $91.57
Mín$93.00
Média$107.57
Máx$130.00
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | · |
| BDX | · | 25.3 | 8.2% | 7.7% | 6.5% | · |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| GEHC | · | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| GMED | · | 22.3 | 16.7% | 18.3% | 12.1% | · |
| GKOS | $6.49B | -34.4 | 32.3% | -37.0% | -26.4% | 55.7% |
| PODD | $20.01B | 81.7 | 30.7% | 9.1% | 16.6% | 71.6% |
Últimas notícias Notícias recentes mencionando esta empresa
Sinais de trading Sinais recentes de compra/venda com preço de entrada e relação risco/recompensa
Nenhum sinal aberto no momento — nenhum cartão está preenchido, e isso é honesto.
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Fonte: SEC 10-Q arquivado Ago 5, 2026